Hypertension Myocardial Fibrosis
View Full Paper
Ask AI
Bookmark
Share
Key result
Mineralocorticoid receptor antagonism, similar to AT1 antagonism, improves cardiovascular outcomes by decreasing oxidative stress, inflammation, and fibrosis associated with chronic pressure overload.
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Emphasizes the importance of mineralocorticoid receptor antagonism in mitigating hypertensive myocardial fibrosis and adverse cardiac remodeling.
PICO
P
Population
Hypertensive cardiac remodeling and myocardial fibrosis
I
Intervention / Comparator
Mineralocorticoid receptor antagonists
Emphasizes the importance of mineralocorticoid receptor antagonism in mitigating hypertensive myocardial fibrosis and adverse cardiac remodeling.
Cite This Study
James R. Sowers (2007) conducted an editorial in Hypertensive cardiac remodeling and myocardial fibrosis. Mineralocorticoid receptor antagonists was evaluated. Mineralocorticoid receptor antagonism, similar to AT1 antagonism, improves cardiovascular outcomes by decreasing oxidative stress, inflammation, and fibrosis associated with chronic pressure overload.
Topics
View Full Paper
Ask AI
Bookmark
Share